Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22751| Title: | Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001. | Austin Authors: | Paz-Ares, L;Doebele, R C;Farago, A F;Liu, S V;Chawla, S P;Tosi, D;Blakely, C M;Krauss, J C;Sigal, D;Bazhenova, L;John, Thomas ;Besse, B;Wolf, J;Seto, T;Chow-Maneval, E;Ye, C;Simmons, B;Demetri, G D | Affiliation: | Hospital 12 de Octubre, Madrid, Spain Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia University of Colorado, Aurora, CO, USA Massachusetts General Hospital, Boston, MA, USA Georgetown University, Washington, DC, USA Sarcoma Oncology Research Center, Santa Monica, CA, USA Medical Oncology Departement, Institut du Cancer de Montpellier Inserm U1194, Montpellier University, Montpellier, France University of California, San Francisco, CA, USA University of Michigan, Ann Arbor, MI, USA Scripps Clinic, La Jolla, CA, USA University of California, San Diego, CA, USA Gustave Roussy Cancer Campus, Villejuif, France University Hospital of Cologne, Cologne, Germany National Kyushu Cancer Center, Fukuoka, Japan Ignyta, Inc., San Diego, CA, USA Genentech, South San Francisco, CA, USA Dana-Farber Cancer Institute, Boston, MA, USA |
Issue Date: | Apr-2019 | Publication information: | Annals of oncology : official journal of the European Society for Medical Oncology 2019; 30 Suppl 2: ii48-ii49 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/22751 | DOI: | 10.1093/annonc/mdz063.011 | Journal: | Annals of oncology : official journal of the European Society for Medical Oncology | PubMed URL: | 32131246 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.